U.S. Markets close in 4 hrs 10 mins

Amgen Inc. (AMGN)

NASDAQ Global Select - NASDAQ Global Select Real Time Price. Currency in USD
Add to watchlist
170.42+2.26 (+1.34%)
As of 11:50AM EDT. Market open.
People also watch
Full screen
Previous Close168.16
Bid170.29 x 100
Ask170.33 x 500
Day's Range168.83 - 170.53
52 Week Range133.64 - 184.21
Avg. Volume3,150,610
Market Cap124.35B
PE Ratio (TTM)16.19
Earnings DateN/A
Dividend & Yield4.60 (2.75%)
Ex-Dividend Date2017-08-15
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com2 hours ago

    Three Biotech Stocks To Buy Amid The (Unsurprising) Dip

    Biotech has underperformed the broader market this month, but Jefferies' Michael Yee writes that that's not really a concern--or a surprise. A little more detail about each: AMGN: key incoming questions around scenarios for upcoming REGN injunction appeals decision where buyside consensus is for majority likelihood AMGN wins with some pot'l for court trying to force a financial settlement w/ large royalty (worth $2-3/share). If AMGN loses, there shouldn't be any change to estimates given consensus has not adjusted any 2018+ PCSK9 numbers for a win though AMGN already won the initial federal injunction decision.

  • GuruFocus.com4 days ago

    Amgen in Collaboration With Humana for Patients' Benefit

    The companies will also have a deep focus into specific therapeutic areas

  • Market Realist5 days ago

    Where Amgen’s Enbrel and Nplate Stand after 2Q17

    In 2Q17, Amgen’s (AMGN) Enbrel generated revenues of ~$1.5 billion, which represented a ~1% year-over-year decline and a ~24% quarter-over-quarter rise.